Skyrizi 150 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26FV659
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $58,513
Award facts
- Contract value 100% obligated
- $58,512.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $58,512.80, represents a firm fixed-price purchase of SKYRIZI 150 mg/ml under an indefinite delivery contract vehicle. The award was issued on January 20, 2026, to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc., with final completion scheduled for January 21, 2026. The contract was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. SKYRIZI, a specialty pharmaceutical product, will be supplied to support federal medical procurement needs through the Defense Logistics Agency (DLA).
This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The DLA's Pharmaceutical Prime Vendor Global Program Generation V strategy aims to establish multiple regional awards, positioning AmerisourceBergen among key federal pharmaceutical distributors serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FV659?
SPE2DR26FV659 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FV659 worth?
The government has obligated $58,513 on SPE2DR26FV659.
Is contract SPE2DR26FV659 an order under another contract?
Yes. SPE2DR26FV659 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV659 competed?
The extent of competition for SPE2DR26FV659 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award